OQS
ETTX

Occudo Quantitative Strategies’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Occudo Quantitative Strategies’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-23,221
Closed -$51K – 1398
2021
Q4 		$51K Buy
23,221
+764
+3% +$2.06K ﹤0.01% 1010
2021
Q3 		$75K Sell
22,457
-601
-3% -$1.63K 0.01% 942
2021
Q2 		$62K Sell
23,058
-5,973
-21% -$13.5K 0.01% 835
2021
Q1 		$62K Buy
29,031
+14,589
+101% +$41.5K 0.01% 714
2020
Q4 		$36K Buy
+14,442
New +$28.4K 0.01% 624

Other funds holding ETTX

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return

Occudo Quantitative Strategies's ETTX Position: Q1 2022 in Review

Occudo Quantitative Strategies sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q1 2022, closing a stake of 23,221 shares — an estimated $51K sold.

Occudo Quantitative Strategies first reported a position in ETTX in Q4 2020 and held it in 5 quarters. The position peaked at $75K in Q3 2021. 22 funds tracked by Wall St. Rank hold ETTX as of Q1 2022.

  • Occudo Quantitative Strategies reported no remaining Entasis Therapeutics Holdings Inc. position as of Q1 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 23,221 Entasis Therapeutics Holdings Inc. shares in Q1 2022, an estimated $51K.
  • Occudo Quantitative Strategies first reported a position in Entasis Therapeutics Holdings Inc. in Q4 2020 and held it in 5 quarters.
  • Occudo Quantitative Strategies's Entasis Therapeutics Holdings Inc. position peaked at $75K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q1 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2022, filed 16 May 2022.